EC-0371

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameEC-0371
Drug Alias NameFc-rapa (Endocyte)folate-conjugated rapamycin (Endocyte)EC-0371
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsPolycystic Kidney, Autosomal Dominant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEndocyte Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEndocyte Inc
Active IndicationsN/A
Inactive IndicationsPolycystic Kidney, Autosomal Dominant

Other Information

ATC CodeN/A
Related LinksN/A